Template-guided saturation prostate biopsies are no longer necessary when high-quality state-of- the-art multiparametric magnetic resonance image (mpMRI) is available, but suspicious lesions should always be confirmed by targeted biopsy, according to consensus panel findings published online ahead of print in BJU International.

The panel, which included urologic surgeons, radiologists, and basic researchers from Europe and North America, also concluded that mpMRI is the “optimum approach to achieve the objectives needed for focal therapy” if made on a high-quality machine and judged by an experienced radiologist. It also agreed that state-of-the-art mpMRI is the technique of choice for focal ablation follow-up, but concluded that mpMRI is not accurate enough to grade tumor aggressiveness consistently.